For pancreatic cancer patients, the surge in interest for an exciting new drug is leaving them fearful about when they might get the treatment or if there will be enough…
Vetenskapsnyheter
Assessing the health secretary's biggest challenges, and a look at new rules that inject politics into the NIH.
Inceptive Nucleics and Alnylam's partnership, why Grail's "failed" trial still matters, and other biotech news from The Readout
In this edition of STAT Health Tech: An update on the Utah pilot that uses a chatbot to renew drug prescriptions, AI scribes for patients, and more.
Eli Lilly is halving its originally planned investment in the production of weight loss syringes in Germany in response to a cost-cutting law
An Ebola update, Trump to strip job protections of NIH officials, and more health news from Morning Rounds
Revolution Medicines' pancreatic cancer drug has not yet been approved — and already talk has shifted to how (and when) its use might be expanded.
An oncologist shares three lessons from the world’s first randomized trial on a multi-cancer early detection.
What happens at a longevity festival? On this week's STATus Report, Alex Hogan gets a dispatch from STAT's Sarah Todd.
Ambient scribes were the first large-scale application of AI in health care. Now developers are pitching them as diligent note-takers for patients.
“One of the cancer community’s worst fears is coming to pass,” writes Gwen Nichols of Blood Cancer United.
Due to a significant gender gap, far less is known about the health risks of early or late puberty onset among boys than girls.
Among the affected positions, which the White House estimates to be 8,000, are high-level officials who oversee research grants from the NIH.
Alnylam announced a three-year deal with Inceptive Nucleics, worth up to $2 billion, with $30 million upfront in cash and equity in the startup.
Highmark Health is the fourth insurer to sue HaloMD, seeking to overturn arbitration wins.
In this edition of STAT's AI Prognosis: Brittany Trang analyzes the pope's encyclical on artificial intelligence for takeaways relevant for health care.
New guidance for gene therapy developers, Lilly's deal for kidney drugs, and more biotech news from The Readout
Taking weight loss drugs for at least three years could prevent thousands of knee replacements a year, a new study found
A brief hantavirus update, some good news about death, and more health news from Morning Rounds
A survey finds that ultra-processed foods are a cross-partisan concern. And yet policy has been slow to follow.
While NIH-funded centers weren’t on the front lines of virus responses like the CDC or USAID, some researchers involved in the network said the cuts have damaged relationships with experts…
“Public health is going to have to talk about the Amish more and more”: Listen to STAT’s "First Opinion Podcast" on the Amish and health care.
“Much of the rhetoric, imagery, and policy messaging from the Trump administration centers on extreme masculine ideals,” First Opinion author writes.
“The financial side effects of care have become clinical ones,” writes Darshak Sanghavi.
Advocates were already dreading Medicaid's work requirements. New rules are worse than they feared.